国家神经系统疾病临床医学研究中心数据管理与共享系统
Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
2018-08-01
已发表文章
主要研究背景及目的
方法
Recently, due to the advanced neuroimaging techniques and biochemical tests, various biomarkers are gradually identified, providing the ability to detect the evidence of AD pathology in the preclinical stage and further intervene the process of disease. Multimodal magnetic resonance imaging (MRI), with relatively non-invasive and economic benefits, is of great values to promote the clinical application.
结论
Therefore, researches involving brain structural and functional alterations in preclinical AD are summarized in this review.